First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826

Monk, Bradley J.; Colombo, Nicoletta; Tewari, Krishnansu S.; Dubot, Coraline; Caceres, M. Valeria; Hasegawa, Kosei; Shapira-Frommer, Ronnie; Salman, Pamela; Yañez, Eduardo; Gümüş, Mahmut; Olivera Hurtado de Mendoza, Mivael; Samouëlian, Vanessa; Castonguay, Vincent; Arkhipov, Alexander; Tekin, Cumhur; Li, Kan; Keefe, Stephen M.; Lorusso, Domenica; Null, Null